While our previous discussion has focused on the metabolic characteristics of CD8+ T cells in anti-tumor immunity, it is equally important to consider the metabolic programming of other T cell subsets that regulate anti-tumor immune responses within the TME. This evidence concerns the gene CD8A and neoplasm.